USPTO serial 99531114
ENCLOSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2026
- Examiner
- HWANG, JOHN C B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ENCLOSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Guy F. Birkenmeier
Guy F. Birkenmeier New England Biolabs240 County RoadIpswich, MA 01938United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; Chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; Enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; Chemicals, enzymes, nucleic acid constructs and viral vectors for scientific and research use; Nucleic acid constructs and viral vectors for use in the manufacture of nucleic acids; Nucleic acid constructs and viral vectors for manufacturing viruses; Nucleic acid constructs and viral vectors for use in scientific research, agribiotechnology, and nanotechnology; all of the aforementioned goods not for medical or veterinary use; Reagents for scientific or medical research use; Enzymes for scientific and research purposes; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Reagents for scientific and research use; Chemical preparations for scientific purposes; Biochemicals for in vitro and in vivo scientific use; Biochemical preparations for scientific purposes; Reagents for scientific use; Chemical reagents for scientific purposes; Reagents for scientific purposes; Chemical preparations for scientific purposes, other than for medical or veterinary use; Nucleic acids for scientific purposes; Biochemical preparations for scientific use; Chemical reagents for non-medical purposes; Chemical reagents, other than for medical or veterinary purpose; Chemical reagents, other than for medical or veterinary purposes; Biochemical reagents, other than for medical or veterinary purposes; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Reagents for research purposes; Reagents for medical research; Reagents for research use; Biochemical preparations for laboratory purposes; Biochemical preparations for laboratory use | ACTIVE | Mar 17, 2026 |
| 005 | Reagents for medical use; Reagents for medical purposes; Reagents for veterinary use; Chemical reagents for medical purposes; Biological reagents for medical purposes; Biological reagents for medical use; Chemical reagents for medical use; Enzymes for medical purposes; Nucleic acid constructs for medical and veterinary purposes; Nucleic acid constructs and viral vectors for use as prophylactic or therapeutic vaccines; Nucleic acid constructs and viral vectors for the production of prophylactic or therapeutic vaccines; Nucleic acid constructs and viral vectors for medical use; Nucleic acid constructs and viral vectors for the production of therapeutic or prophylactic viruses; Nucleic acid constructs and viral vectors for gene therapy; Nucleic acid constructs and viral vectors for use in cell therapy; Nucleic acid constructs and viral vectors for use in genome editing; Nucleic acid constructs and viral vectors for use in therapy | ACTIVE | Mar 17, 2026 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by New England Biolabs, Inc.
- Other trademarks owned by New England Biolabs, Inc.
- Other trademarks owned by New England Biolabs, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named ENCLOSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 15, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 25, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 25, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 25, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 14, 2026 | IUAF | USE AMENDMENT FILED | — |
| Jul 14, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 14, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jun 30, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 5, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 5, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 29, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 9, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 8, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 4, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 4, 2025 | NWAP | NEW APPLICATION ENTERED | — |